| Website | ensysce.com |
| Category | BioTech |
| Employees | |
| Founded | 2008 |
| TOTAL | $2.5M |
| FUNDING TOTAL | $2.5M |
| Series A, 6/10 The Texas Emerging Technology Fund | $1.5M |
| Venture Round, 6/12 The Texas Emerging Technology Fund | $1M |
Ensysce Biosciences, Inc., a nanotechnology company, engages in the research on the use of fullerene carbon nanotubes for novel therapeutic applications in the area of cancer treatment. Its fullerene carbon nanotubes are used in delivering active agents into the cancer cells through natural barriers and protecting normal tissue from the active agent during delivery. The company also delivers small interfering RNA for cancer treatment, active cancer drugs, and alpha-emitting radiation using carbon nanotubes. Ensysce Biosciences, Inc. was founded in 2008 and is based in Houston, Texas.
